Prognostic value of early imaging following CAR-T cell therapy in diffuse large B-cell lymphoma

Leuk Lymphoma. 2022 Jun;63(6):1492-1495. doi: 10.1080/10428194.2022.2032039. Epub 2022 Feb 3.

Authors

Amneet Bajwa¹, Ying Huang², Rui Li², Nathan Denlinger², Jonathan Brammer², Sam Penza², Ayman Saad², Samantha Jaglowski², Adam S Kittai²

Affiliations

¹ Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
² Division of Hematology, The Ohio State University, Columbus, OH, USA.

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD19
Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / methods
Lymphoma, Large B-Cell, Diffuse* / diagnostic imaging
Lymphoma, Large B-Cell, Diffuse* / therapy
Prognosis
Receptors, Chimeric Antigen*

Substances

Antigens, CD19
Receptors, Chimeric Antigen

Grants and funding

T32 CA090223/CA/NCI NIH HHS/United States